Daily Stock Analysis, BSTG, Harvard Apparatus Regenerative Technology Inc , priceseries

Harvard Apparatus Regenerative Technology Inc . Daily Stock Analysis
Stock Information
Open
0.11
Close
0.10
High
0.11
Low
0.09
Previous Close
0.11
Daily Price Gain
-0.01
YTD High
0.95
YTD High Date
Jan 3, 2017
YTD Low
0.09
YTD Low Date
Oct 9, 2017
YTD Price Change
-0.77
YTD Gain
-87.93%
52 Week High
1.42
52 Week High Date
Dec 1, 2016
52 Week Low
0.09
52 Week Low Date
Oct 9, 2017
52 Week Price Change
-0.78
52 Week Gain
-88.07%
Company Information
Stock Symbol
BSTG
Exchange
NasdaqCM
Company URL
http://http://www.harvardapparatusregen.com
Company Phone
(774) 233-7300
CEO
James J. McGorry
Headquarters
Massachusetts
Business Address
84 OCTOBER HILL ROAD, SUITE 11, HOLLISTON, MA 01746
Sector
-
Industry Category
-
Industry Group
-
CIK
0001563665
About

Harvard Apparatus Regenerative Technology, Inc., a clinical stage biotechnology company, develops and commercializes regenerated organs for human transplant.

Description

Harvard Apparatus Regenerative Technology, Inc., a clinical stage biotechnology company, develops and commercializes regenerated organs for human transplant. The company is developing the HART-Trachea, which includes a scaffold, the patient’s cells, and a bioreactor to restore the structure and/or function of a severely damaged trachea; and automated solid organ bioreactor that has the ability to seed cells on an organ scaffold and keep them sterile and healthy during the growth phase prior to transplant. Its pre-clinical stage products include human-sized synthetic scaffold prototypes for esophageal transplant. The company has a pre-clinical collaboration with Connecticut Children's Medical Center to develop a process for repairing or replacing the esophagus to treat life-threatening pediatric conditions, such as esophageal atresia. Harvard Apparatus Regenerative Technology, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts.